Chen, Kai http://orcid.org/0000-0002-3325-3536
Stahl, Elizabeth C.
Kang, Min Hyung
Xu, Bryant
Allen, Ryan
Trinidad, Marena
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
Funding for this research was provided by:
Howard Hughes Medical Institute
Article History
Received: 27 October 2023
Accepted: 9 February 2024
First Online: 26 February 2024
Change Date: 1 May 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-48087-6
Competing interests
: The Regents of the University of California have filed patent applications for self-deliverable CRISPR RNPs under WO 2024/011176, where J.A.D. and K.C. are inventors. J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics, and Mammoth Biosciences. J.A.D. is a scientific advisory board member or consultant for Vertex, Caribou Biosciences, Intellia Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Algen Biotechnologies, Felix Biosciences, The Column Group, and Inari. J.A.D. is Chief Science Advisor to Sixth Street, a Director at Altos, Johnson & Johnson and Tempus, and she has research projects sponsored by Apple Tree Partners and Roche. The remaining authors declare no competing interests.